Breaking News

Meissner to Invest $250M in New Manufacturing Facility in Georgia

The new site will include state-of-the-art cleanroom facilities, laboratories, research and development, and office spaces.

Meissner Corporation, a company involved in advanced microfiltration and therapeutic manufacturing systems for the development and manufacture of pharmaceuticals, therapeutics, biologics, and cell and gene therapies, will invest nearly $250 million in a new manufacturing facility in Athens-Clarke County, Georgia. The project will create more than 1,700 new jobs over the next eight years. Meissner’s new facility will be located at the Christian Industrial Tract, located at 1310 Spring Valle...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters